BioMerieux is a niche player in the fragmented in vitro diagnostic market and has specialty positioning in clinical and industrial microbiology and multiplex molecular diagnostics, or syndromic ...
MARCY-L'ÉTOILE, France, Feb. 18, 2026 /PRNewswire/ -- bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™, an innovative solution designed to ...
BioMerieux is a niche player in the fragmented in vitro diagnostic market and has specialty positioning in clinical and industrial microbiology and syndromic (multiplex) molecular diagnostics. With ...
MARCY L'ÉTOILE, France, March 18, 2025 /PRNewswire/ --bioMérieux, a world leader in the field of in vitro diagnostics, announces the U.S. Food and Drug Administration (FDA) 510(k) clearance for VITEK® ...
From the polio vaccine to the EMT profession, many notable medical advancements have come out of the University of Pittsburgh. With a French biotech company on board, the university’s leadership hopes ...
OhioHealth is only the 4 th to receive the designation in the country, and the first regional healthcare system. The bioMérieux AMS Center of Excellence initiative represents a unique set of health ...
In this Lab Week virtual symposium, bioMérieux celebrates Medical Laboratory Professionals by providing education and learning opportunities to support the life-changing work you and your labs do for ...
Revenue: EUR4 billion, growing 6.2% organically. EBIT Margin: 17.9% of sales, growing 16% organically. Cash Flow: EUR460 million, growing 40% versus 2024. BIOFIRE Installations: 1,800 units in 2025, 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results